Kazuomi KarioSatoshi HoshideYook Chin ChiaPeera BuranakitjaroenSaulat SiddiqueJinho ShinYuda TuranaSungha ParkKelvin TsoiChen Huan ChenHao Min ChengTakeshi FujiwaraYan LiVan Minh HuynhMichiaki NagaiJennifer NailesJorge SisonArieska Ann SoenartaGuru Prasad SogunuruApichard SukonthasarnJam Chin TayBoon Wee TeoNarsingh VermaTzung Dau WangYuqing ZhangJi Guang WangHiroshima City Asa Citizens HospitalSiriraj HospitalUniversity Medicine and Pharmacy, Hue UniversitySunway UniversityHanyang University Medical CenterJichi Medical UniversityYonsei University Health SystemShanghai Jiao Tong University School of MedicineMadras Institute of Orthopaedics and Traumatology HospitalsNational Taiwan University HospitalKathmandu UniversityUniversity of the East Ramon Magsaysay Memorial Medical CenterNational Yang-Ming University TaiwanUniversitas Katolik Indonesia Atma JayaUniversitas IndonesiaUniversiti MalayaFuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical CollegeNUS Yong Loo Lin School of MedicineKing George's Medical UniversityVeterans General Hospital-TaipeiChinese University of Hong KongTan Tock Seng HospitalChiang Mai UniversityMedical Center ManilaPunjab Medical Center2022-08-042022-08-042021-03-01Journal of Clinical Hypertension. Vol.23, No.3 (2021), 411-42117517176152461752-s2.0-85103146577https://repository.li.mahidol.ac.th/handle/20.500.14594/78371Hypertension is an important public health issue due to its association with a number of serious diseases, including cardiovascular disease and stroke. The importance of evaluating hypertension taking into account different blood pressure (BP) profiles and BP variability (BPV) is increasingly being recognized, and is particularly relevant in Asian populations given the specific features of hypertension in the region (including greater salt sensitivity and a high rate of nocturnal hypertension). Ambulatory BP monitoring (ABPM) is the gold standard for diagnosing hypertension and assessing 24-hour BP and provides data on several important parameters that cannot be obtained using any other form of BP measurement. In addition, ABPM parameters provide better information on cardio- and cerebrovascular risk than office BP. ABPM should be used in all patients with elevated BP, particularly those with unstable office or home BP, or who are suspected to have white-coat or masked hypertension. ABPM is also an important part of hypertension diagnosis and monitoring in high-risk patients. ABPM needs to be performed using a validated device and good practice techniques, and has a role both in hypertension diagnosis and in monitoring the response to antihypertensive therapy to ensure strict BP control throughout the 24-hour period. Use of ABPM in clinical practice may be limited by cost and accessibility, and practical education of physicians and patients is essential. The ABPM evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for ABPM in Asia.Mahidol UniversityMedicineReviewSCOPUS10.1111/jch.14128